BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RXDX
3201
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $22.3M | ﹤0.01% |
940,120
+942
| +0.1% | +$22.2K |
|
3202
State Street Materials Select Sector SPDR ETF
XLB
$8.57B
| $22.3M | ﹤0.01% |
563,292
-35,060
| -6% | -$1.46M |
|
3203
MetroCity Bankshares
MCBS
$1.04B
| $22.3M | ﹤0.01% |
1,061,184
-32,172
| -3% | -$639K |
|
3204
Applied Optoelectronics
AAOI
$11B
| $22.2M | ﹤0.01% |
3,090,324
+94,649
| +3% | +$698K |
|
3205
James Hardie Industries
JHX
$17.9B
| $22.1M | ﹤0.01% |
619,640
+21,419
| +4% | +$785K |
|
3206
ACM Research
ACMR
$5.65B
| $22M | ﹤0.01% |
601,332
+5,343
| +0.9% | +$163K |
|
3207
UWM Holdings
UWMC
$2.61B
| $22M | ﹤0.01% |
3,167,267
+1,175,617
| +59% | +$8.75M |
|
3208
Ultrapar
UGP
$6.22B
| $21.9M | ﹤0.01% |
8,108,993
-897,223
| -10% | -$2.83M |
|
|
AKUS
3209
DELISTED
Akouos Inc
AKUS
| $21.8M | ﹤0.01% |
1,878,650
+32,016
| +2% | +$384K |
|
|
BVH
3210
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $21.8M | ﹤0.01% |
843,598
-16,238
| -2% | -$336K |
|
|
CIIGU
3211
DELISTED
CIIG Capital Partners II, Inc. Unit
CIIGU
| $21.7M | ﹤0.01% |
+2,156,250
| New | +$21.7M |
|
3212
iShares MSCI Italy ETF
EWI
$1.08B
| $21.7M | ﹤0.01% |
685,297
-134,362
| -16% | -$4.37M |
|
3213
Cenovus Energy
CVE
$56.4B
| $21.6M | ﹤0.01% |
2,150,416
-17,794
| -0.8% | -$152K |
|
3214
Main Street Capital
MAIN
$5.47B
| $21.6M | ﹤0.01% |
525,860
+109,719
| +26% | +$4.56M |
|
3215
Lineage Cell Therapeutics
LCTX
$268M
| $21.6M | ﹤0.01% |
8,551,700
+12,170
| +0.1% | +$31.2K |
|
|
MSP
3216
DELISTED
Datto Holding Corp.
MSP
| $21.5M | ﹤0.01% |
900,525
+35,344
| +4% | +$915K |
|
3217
Greif Class B
GEF.B
$4.24B
| $21.5M | ﹤0.01% |
332,005
-7,883
| -2% | -$484K |
|
3218
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.2B
| $21.5M | ﹤0.01% |
518,189
+379,061
| +272% | +$15.8M |
|
3219
Artesian Resources
ARTNA
$362M
| $21.5M | ﹤0.01% |
563,362
-788
| -0.1% | -$30.3K |
|
|
CAJ
3220
DELISTED
Canon, Inc.
CAJ
| $21.5M | ﹤0.01% |
881,080
+42,633
| +5% | +$1.02M |
|
|
HTPA.U
3221
DELISTED
Highland Transcend Partners I Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
HTPA.U
| $21.5M | ﹤0.01% |
2,055,081
-45,011
| -2% | -$456K |
|
|
APLT
3222
DELISTED
Applied Therapeutics
APLT
| $21.5M | ﹤0.01% |
1,292,817
-19,285
| -1% | -$333K |
|
3223
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $21.4M | ﹤0.01% |
779,810
-39,496
| -5% | -$1.1M |
|
3224
Citizens
CIA
$199M
| $21.4M | ﹤0.01% |
3,449,693
-28,860
| -0.8% | -$164K |
|
|
SEI
3225
Solaris Energy Infrastructure
SEI
$3.94B
| $21.3M | ﹤0.01% |
2,557,377
-23,872
| -0.9% | -$194K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.